Epilepsia® – A Journal of the ILAE
Epilepsia® is the world's leading journal of original scientific research and commentary in epileptology. Impact Factor: 6.040
- Editors, Associate Editors and Editorial Board
- Most Accessed
- Most Cited
- Gray Matters
- Epilepsia® table of contents - February 2021
- Epilepsia® website: www.epilepsia.com: Access to the items above, and more.
- Epilepsia® Prize
- Epilepsia SEO Tips for Authors
Chapter member discount subscription prices
Online version only:
- NEW! Low and Lower Middle Income Countries and Upper Middle Income Countries with per capita GDP lower than $8,000: $0.00
- Upper Middle Income Countries with per capita GDP greater than $8,000: $35.00
- High Income Countries: $45.00
Paper and Online version: $75.00
American Epilepsy Society and Japanese Epilepsy Society members receive a full subscription to Epilepsia® as a member benefit.
Changes in Epilepsia access and pricing
The Editors-in-chief of Epilepsia, the ILAE Executive Committee, and Epilepsia's publisher, Wiley have approved changes in subscription access and pricing. For many years, all content older than one year has been freely available in the Wiley Online Library though Wiley was not obligated to make it freely available. Effective immediately, this policy will change so that content older than four years will be freely available. Articles of high importance to our community (e.g. definitions, classifications, guidelines, selected ILAE reports) as well as articles for which authors have paid open access fees will continue to be freely accessible without restriction as soon as they are published. This change was necessary because having a very large fraction of the Epilepsia content freely available created a risk that libraries would cancel their subscriptions, making Epilepsia less available to some and reducing the income derived by ILAE from subscriptions to Epilepsia.
To help alleviate the burden of this change, ILAE and Wiley decided that free e-only subscriptions to Epilepsia will now be available to ILAE Chapters members from countries belonging to the Upper Middle Income group if they have a per capita GDP lower than $8,000. This currently represents 36 countries, in addition to countries in the Lower Income and Lower Middle Income groups. Subscribe here to receive these free subscriptions.
Please note that if you currently access Epilepsia content via your institution, through a member subscription, or through the Hinari system, these changes will not affect you and your access to all content will continue.
Mission: Epilepsia® is one of the journals of the International League Against Epilepsy (ILAE). The Journal publishes original articles on all aspects of epilepsy, clinical and experimental. The journal also publishes timely reviews, as well as commission and task force reports from various ILAE groups.
Target readership: Professionals and experts who treat and do research related to all aspects of epilepsy.
Target authorship: Any health care professional, clinical researcher or basic scientists involved in epilepsy related research. Instructions for Authors
Types of articles: Regular articles and brief communications (excluding single case reports unless of particular clinical or research importance). Invited reviews, Commentaries, and Controversies require approval prior to submission or they will not be accepted for peer review.
Special features: Supplements are considered based on topic. Prospective authors should contact the editorial office at email@example.com
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community